Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Carmella Evans‐Molina, Piero Marchetti et al.|EBioMedicine|2025Cited by 14
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in miceFarooq Syed, Carmella Evans‐Molina, Lorella Marselli et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
Pharmacological Inhibition of Tyrosine Protein-Kinase 2 Reduces Islet Inflammation and Delays Type 1 Diabetes Onset in MiceFarooq Syed, Carmella Evans‐Molina, Piero Marchetti et al.|SSRN Electronic Journal|2024Cited by 3
Altered B Cell Metabolic Pathways Characterize Type 1 Diabetes ProgressionHolly Conway, Jamie L. Felton|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2
A parallax view of type 1 diabetesStaci A. Weaver, Carmella Evans‐Molina, Jamie L. Felton|The Biochemist|2021Cited by 1